30 commercial payer policies list J3401. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
30 policies from 22 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J3401 |
|---|---|---|
| Vyjuvek (beremagene geperpavec-svdt) | Feb 1, 2026 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Vyjuvek (beremagene geperpavec-svdt)Effective 11/01/2023 - 11/30/2024 | Nov 1, 2023 | Prior auth requiredInferred from policy title |
| Vyjuvek (beremagene geperpavec-svdt)Effective 11/01/2025 - 01/31/2026 | Nov 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Vyjuvek (beremagene geperpavec-svdt)Effective 12/01/2024 - 10/31/2025 | Dec 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J3401 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Vyjuvek (Beramagene Geperpavec-Svdt) | Jan 1, 2026 | Covered |
| Vyjuvek (Beramagene Geperpavec-Svdt) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Vyjuvek (Beramagene Geperpavec-Svdt) – Individual Exchange Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Vyjuvek (Beramagene Geperpavec-Svdt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Vyjuvek (Beramagene Geperpavec-Svdt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Vyjuvek (Beramagene Geperpavec-Svdt) | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Beremagene Geperpavec (Vyjuvek) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Gene Therapies for Treatment of Wounds in Dystrophic Epidermolysis Bullosa | Jun 15, 2026 | Covered |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Gene Therapies for Treatment of Wounds in Dystrophic Epidermolysis Bullosa | Jun 15, 2026 | Covered |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Gene Therapies for Treatment of Wounds in Dystrophic Epidermolysis Bullosa | Jun 15, 2026 | Covered |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Gene Therapies for Treatment of Wounds in Dystrophic Epidermolysis Bullosa | Jun 15, 2026 | Covered |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Vyjuvek | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| VYJUVEK | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| VYJUVEK (BEREMAGENE GEPERPAVEC) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Beremagene Geperpavec-svdt (Vyjuvek) | Aug 30, 2023 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Vyjuvek (beremagene geperpavec) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Beremagene Geperpavec-svdt (Vyjuvek); CP.PHAR.592 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Gene therapy for dystrophic epidermolysis bullosa (Vyjuvek, Zevaskyn) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Beremagene Geperpavec (Vyjuvek) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| 00864 beremagene geperpavec-svdt (Vyjuvek) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Vyjuvek | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Vyjuvek (beremagene geperpavec-svdt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Vyjuvek (beremagene geperpavec-svdt) (PG147, Ver. 4) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3401 |
|---|---|---|
| Vyjuvek (Beramagene Geperpavec-Svdt) | Jan 1, 2026 | Covered |